ZN-c3 + Gemcitabine in Pancreatic Cancer

Clinical trial NCT06015659 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06015659
Sponsor: Brandon Huffman, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Adenocarcinoma Pancreatic Cancer Pancreatic Ductal Adenocarcinoma

Start date: 2023-11-16
Primary completion: 2025-08-06
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.